BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol 2014; 20(1): 6-21 [PMID: 24415853 DOI: 10.3748/wjg.v20.i1.6] [Cited by in CrossRef: 269] [Cited by in F6Publishing: 252] [Article Influence: 33.6] [Reference Citation Analysis]
Number Citing Articles
1 Tian T, Wang Z, Zhang J. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies. Oxid Med Cell Longev 2017;2017:4535194. [PMID: 28744337 DOI: 10.1155/2017/4535194] [Cited by in Crossref: 144] [Cited by in F6Publishing: 139] [Article Influence: 28.8] [Reference Citation Analysis]
2 Tabarkiewicz J, Pogoda K, Karczmarczyk A, Pozarowski P, Giannopoulos K. The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases. Arch Immunol Ther Exp (Warsz) 2015;63:435-49. [PMID: 26062902 DOI: 10.1007/s00005-015-0344-z] [Cited by in Crossref: 116] [Cited by in F6Publishing: 104] [Article Influence: 16.6] [Reference Citation Analysis]
3 Dou D, Ji Y, Zheng J, Li J, Zhu X, Tang S, Wang H, Li Q, Jing H. A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4+T Cells into Th1 Cells. Dig Dis Sci 2021. [PMID: 34751838 DOI: 10.1007/s10620-021-07300-y] [Reference Citation Analysis]
4 Ke P, Shao BZ, Xu ZQ, Chen XW, Liu C. Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease. Front Immunol 2016;7:695. [PMID: 28119697 DOI: 10.3389/fimmu.2016.00695] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
5 Suh JH, Saba JD. Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire. Transl Cancer Res 2015;4:469-83. [PMID: 27011900 DOI: 10.3978/j.issn.2218-676X.2015.10.06] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
6 Wang Y, Liu K, Qi Z, Chen T, Yu W, Jiang Y, Li G, Xiao H. Therapeutic Mechanism and Effect of Camptothecin on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice. J Immunol Res 2021;2021:5556659. [PMID: 33987448 DOI: 10.1155/2021/5556659] [Reference Citation Analysis]
7 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Warner K, Ohashi PS. ILC regulation of T cell responses in inflammatory diseases and cancer. Seminars in Immunology 2019;41:101284. [DOI: 10.1016/j.smim.2019.101284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 Yasutomi Y, Chiba A, Haga K, Murayama G, Makiyama A, Kuga T, Watanabe M, Okamoto R, Nagahara A, Nagaishi T, Miyake S. Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00185-5. [PMID: 34461283 DOI: 10.1016/j.jcmgh.2021.08.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Shivappa N, Hébert JR, Rashvand S, Rashidkhani B, Hekmatdoost A. Inflammatory Potential of Diet and Risk of Ulcerative Colitis in a Case-Control Study from Iran. Nutr Cancer 2016;68:404-9. [PMID: 27030369 DOI: 10.1080/01635581.2016.1152385] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
11 Gubernatorova EO, Tumanov AV. Tumor necrosis factor and lymphotoxin in regulation of intestinal inflammation. Biochemistry Moscow 2016;81:1309-25. [DOI: 10.1134/s0006297916110092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Aldars-García L, Marin AC, Chaparro M, Gisbert JP. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review. Int J Mol Sci 2021;22:3076. [PMID: 33802883 DOI: 10.3390/ijms22063076] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Peng S, Shen L, Tian MX, Li HM, Wang SS. Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF-κB signaling pathway. Exp Ther Med 2021;21:134. [PMID: 33376516 DOI: 10.3892/etm.2020.9566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Heylen M, Ruyssers NE, Gielis EM, Vanhomwegen E, Pelckmans PA, Moreels TG, De Man JG, De Winter BY. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease. Pharmacol Ther 2014;143:153-67. [PMID: 24603369 DOI: 10.1016/j.pharmthera.2014.02.011] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
15 Sorci G, Lippens C, Léchenault C, Faivre B. Benefits of immune protection versus immunopathology costs: A synthesis from cytokine KO models. Infect Genet Evol 2017;54:491-5. [PMID: 28818622 DOI: 10.1016/j.meegid.2017.08.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
16 Xu XM, Zhang HJ. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World J Gastroenterol 2016; 22(7): 2206-2218 [PMID: 26900285 DOI: 10.3748/wjg.v22.i7.2206] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
17 Ashour RH, Hazem NM, AbdElfattah AA, El-Kady RA, Elmasry A. Pentosan Polysulfate Sodium augments the therapeutic effect of 5-Aminosalicylic Acid in DSS colitis model; the role of IL-35 expression. Int Immunopharmacol 2022;106:108620. [PMID: 35247859 DOI: 10.1016/j.intimp.2022.108620] [Reference Citation Analysis]
18 Yuda M, Yamashita K, Okamura A, Hayami M, Fukudome I, Toihata T, Imamura Y, Mine S, Ishizuka N, Watanabe M. Influence of Preoperative Oropharyngeal Microflora on the Occurrence of Postoperative Pneumonia and Survival in Patients Undergoing Esophagectomy for Esophageal Cancer. Ann Surg 2020;272:1035-43. [PMID: 30946087 DOI: 10.1097/SLA.0000000000003287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
19 Geesala R, Issuree PD, Maretzky T. Novel functions of inactive rhomboid proteins in immunity and disease. J Leukoc Biol 2019;106:823-35. [PMID: 31369701 DOI: 10.1002/JLB.3VMR0219-069R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Cherfane CE, Gessel L, Cirillo D, Zimmerman MB, Polyak S. Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity. Inflamm Bowel Dis. 2015;21:1769-1775. [PMID: 25993688 DOI: 10.1097/mib.0000000000000427] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
21 Rahmani J, Varkaneh HK, Ryan PM, Zarezadeh M, Rashvand S, Clark C, Day AS, Hekmatdoost A. Healthy Eating Index-2015 as a predictor of ulcerative colitis risk in a case-control cohort. J Dig Dis 2019;20:649-55. [PMID: 31634419 DOI: 10.1111/1751-2980.12826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Iraporda C, Romanin DE, Bengoa AA, Errea AJ, Cayet D, Foligné B, Sirard JC, Garrote GL, Abraham AG, Rumbo M. Local Treatment with Lactate Prevents Intestinal Inflammation in the TNBS-Induced Colitis Model. Front Immunol 2016;7:651. [PMID: 28082985 DOI: 10.3389/fimmu.2016.00651] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
23 Chen Y, Liu H, Zhang Q, Luo Y, Wu L, Zhong Y, Tang Z, Pu Y, Lu C, Yin G, Xie Q. Cinacalcet Targets the Neurokinin-1 Receptor and Inhibits PKCδ/ERK/P65 Signaling to Alleviate Dextran Sulfate Sodium-Induced Colitis. Front Pharmacol 2021;12:735194. [PMID: 34880751 DOI: 10.3389/fphar.2021.735194] [Reference Citation Analysis]
24 Lean QY, Eri RD, Fitton JH, Patel RP, Gueven N. Fucoidan Extracts Ameliorate Acute Colitis. PLoS One 2015;10:e0128453. [PMID: 26083103 DOI: 10.1371/journal.pone.0128453] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
25 Melgaço FG, Azamor T, Villar LM, Ano Bom APD, Melgaço JG. Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn's Disease after COVID-19 Vaccination: A Twin Case. Viruses 2021;13:2143. [PMID: 34834950 DOI: 10.3390/v13112143] [Reference Citation Analysis]
26 Lu Q, Yang M, Liang Y, Xu J, Xu H, Nie Y, Wang L, Yao J, Li D. Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. JIR 2022;Volume 15:1825-44. [DOI: 10.2147/jir.s353038] [Reference Citation Analysis]
27 Cai X, Zhang ZY, Yuan JT, Ocansey DKW, Tu Q, Zhang X, Qian H, Xu WR, Qiu W, Mao F. hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis. Stem Cell Res Ther 2021;12:416. [PMID: 34294138 DOI: 10.1186/s13287-021-02492-6] [Reference Citation Analysis]
28 D'Amico F, Nancey S, Danese S, Peyrin-Biroulet L. A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities. J Crohns Colitis 2021;15:152-61. [PMID: 32392336 DOI: 10.1093/ecco-jcc/jjaa093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zheng Y, Yu Y, Chen XF, Yang SL, Tang XL, Xiang ZG. Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease. Front Pharmacol 2021;12:803686. [PMID: 34899362 DOI: 10.3389/fphar.2021.803686] [Reference Citation Analysis]
30 Béres NJ, Kiss Z, Sztupinszki Z, Lendvai G, Arató A, Sziksz E, Vannay Á, Szabó AJ, Müller KE, Cseh Á, Boros K, Veres G. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Dig Liver Dis 2017;49:378-87. [PMID: 28077249 DOI: 10.1016/j.dld.2016.12.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
31 Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Garcia F, Olivares M, Rodríguez-Cabezas ME, Gálvez J. Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Mol Nutr Food Res 2017;61. [PMID: 28752563 DOI: 10.1002/mnfr.201700144] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 11.4] [Reference Citation Analysis]
32 Zhang J, Wang C, Guo Z, Da B, Zhu W, Li Q. miR-223 improves intestinal inflammation through inhibiting the IL-6/STAT3 signaling pathway in dextran sodium sulfate-induced experimental colitis. Immun Inflamm Dis 2021;9:319-27. [PMID: 33332758 DOI: 10.1002/iid3.395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Araruna ME, Serafim C, Alves Júnior E, Hiruma-Lima C, Diniz M, Batista L. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review. Molecules 2020;25:E5430. [PMID: 33233487 DOI: 10.3390/molecules25225430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kleiner G, Zanin V, Monasta L, Crovella S, Caruso L, Milani D, Marcuzzi A. Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17. Exp Ther Med. 2015;9:2047-2052. [PMID: 26136934 DOI: 10.3892/etm.2015.2370] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
35 Ribeiro MF, Oliveira FL, Monteiro-Machado M, Cardoso PF, Guilarducci-Ferraz VV, Melo PA, Souza CM, Calil-Elias S. Pattern of inflammatory response to Loxosceles intermedia venom in distinct mouse strains: a key element to understand skin lesions and dermonecrosis by poisoning. Toxicon 2015;96:10-23. [PMID: 25600642 DOI: 10.1016/j.toxicon.2015.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
36 Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol 2017; 23(33): 6137-6146 [PMID: 28970729 DOI: 10.3748/wjg.v23.i33.6137] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
37 Lahad A, Weiss B. Current therapy of pediatric Crohn’s disease. World J Gastrointest Pathophysiol 2015; 6(2): 33-42 [PMID: 25977836 DOI: 10.4291/wjgp.v6.i2.33] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
38 Din AU, Hassan A, Zhu Y, Zhang K, Wang Y, Li T, Wang Y, Wang G. Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism. J Nutr Biochem 2020;79:108353. [PMID: 32145470 DOI: 10.1016/j.jnutbio.2020.108353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
39 Zhang MH, Wang H, Wang HG, Wen X, Yang XZ. Effective immune-inflammation index for ulcerative colitis and activity assessments. World J Clin Cases 2021; 9(2): 334-343 [PMID: 33521101 DOI: 10.12998/wjcc.v9.i2.334] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Jang JC, Lee KM, Ko SG. Angelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis. Mediators Inflamm 2016;2016:9275083. [PMID: 27293323 DOI: 10.1155/2016/9275083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Fangxiao M, Yifan K, Jihong Z, Yan S, Yingchao L. Effect of Tripterygium wilfordii Polycoride on the NOXs-ROS-NLRP3 Inflammasome Signaling Pathway in Mice with Ulcerative Colitis. Evid Based Complement Alternat Med 2019;2019:9306283. [PMID: 31531121 DOI: 10.1155/2019/9306283] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
42 Abbasi Teshnizi F, Kazemipour N, Nazifi S, Bagheri Lankarani K, Sepehrimanesh M, Razeghian Jahromi I. A study on the potential role of autophagy-related protein 10 as a biomarker for ulcerative colitis. Physiol Rep 2021;9:e14825. [PMID: 33904657 DOI: 10.14814/phy2.14825] [Reference Citation Analysis]
43 Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017;2:17023. [PMID: 29158945 DOI: 10.1038/sigtrans.2017.23] [Cited by in Crossref: 1706] [Cited by in F6Publishing: 1539] [Article Influence: 341.2] [Reference Citation Analysis]
44 Missaghi B, Barkema HW, Madsen KL, Ghosh S. Perturbation of the human microbiome as a contributor to inflammatory bowel disease. Pathogens 2014;3:510-27. [PMID: 25438009 DOI: 10.3390/pathogens3030510] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
45 Pabois J, Durand T, Le Berre C, Gonzales J, Neunlist M, Bourreille A, Naveilhan P, Neveu I. T cells show preferential adhesion to enteric neural cells in culture and are close to neural cells in the myenteric ganglia of Crohn's patients. J Neuroimmunol 2020;349:577422. [PMID: 33068972 DOI: 10.1016/j.jneuroim.2020.577422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Holm TL, Tornehave D, Søndergaard H, Kvist PH, Sondergaard BC, Hansen L, Hermit MB, Holgersen K, Vergo S, Frederiksen KS, Haase C, Lundsgaard D. Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease. Gastroenterol Res Pract 2018;2018:5962624. [PMID: 29849593 DOI: 10.1155/2018/5962624] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
47 da Silva VC, de Araújo AA, de Souza Araújo DF, Souza Lima MCJ, Vasconcelos RC, de Araújo Júnior RF, Langasnner SMZ, de Freitas Fernandes Pedrosa M, de Medeiros CACX, Guerra GCB. Intestinal Anti-Inflammatory Activity of the Aqueous Extract from Ipomoea asarifolia in DNBS-Induced Colitis in Rats. Int J Mol Sci 2018;19:E4016. [PMID: 30545135 DOI: 10.3390/ijms19124016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
48 Ramírez-rico G, Drago-serrano ME, León-sicairos N, de la Garza M. Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer. Front Pharmacol 2022;13:855852. [DOI: 10.3389/fphar.2022.855852] [Reference Citation Analysis]
49 Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667-685. [PMID: 25234148 DOI: 10.1038/nri3738] [Cited by in Crossref: 647] [Cited by in F6Publishing: 600] [Article Influence: 80.9] [Reference Citation Analysis]
50 Jiminez JA, Uwiera TC, Douglas Inglis G, Uwiera RR. Animal models to study acute and chronic intestinal inflammation in mammals. Gut Pathog 2015;7:29. [PMID: 26561503 DOI: 10.1186/s13099-015-0076-y] [Cited by in Crossref: 98] [Cited by in F6Publishing: 85] [Article Influence: 14.0] [Reference Citation Analysis]
51 Jones GR, Brown SL, Phythian-Adams AT, Ivens AC, Cook PC, MacDonald AS. The Methyl-CpG-Binding Protein Mbd2 Regulates Susceptibility to Experimental Colitis via Control of CD11c+ Cells and Colonic Epithelium. Front Immunol 2020;11:183. [PMID: 32117307 DOI: 10.3389/fimmu.2020.00183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Erbach J, Bonn F, Diesner M, Arnold A, Stein J, Schröder O, Aksan A. Relevance of Biotin Deficiency in Patients with Inflammatory Bowel Disease and Utility of Serum 3 Hydroxyisovaleryl Carnitine as a Practical Everyday Marker. JCM 2022;11:1118. [DOI: 10.3390/jcm11041118] [Reference Citation Analysis]
53 Lee AS, Lee KM, Lee J, Choi I. Peanut shell extract inhibits the development of dextran sulfate sodium (DSS)-induced colitis. International Immunopharmacology 2019;70:235-40. [DOI: 10.1016/j.intimp.2019.02.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
54 Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev 2021;175:113828. [PMID: 34157320 DOI: 10.1016/j.addr.2021.113828] [Reference Citation Analysis]
55 Alshehri D, Saadah O, Mosli M, Edris S, Alhindi R, Bahieldin A. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Bosn J Basic Med Sci 2021;21:270-83. [PMID: 33052081 DOI: 10.17305/bjbms.2020.5016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lombardi S, Fuoco I, di Fluri G, Costa F, Ricchiuti A, Biondi G, Nardini V, Scarpato R. Genomic instability and cellular stress in organ biopsies and peripheral blood lymphocytes from patients with colorectal cancer and predisposing pathologies. Oncotarget 2015;6:14852-64. [PMID: 26046795 DOI: 10.18632/oncotarget.4032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
57 Chen L, Zhou Z, Yang Y, Chen N, Xiang H. Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice. PLoS One. 2017;12:e0186138. [PMID: 29049372 DOI: 10.1371/journal.pone.0186138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
58 Zou J, Liu C, Jiang S, Qian D, Duan J. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis. Infect Immun 2021;89:e0001421. [PMID: 33526559 DOI: 10.1128/IAI.00014-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Manuc TE, Manuc MM, Diculescu MM. Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets. Clin Exp Gastroenterol 2016;9:59-70. [PMID: 27042137 DOI: 10.2147/CEG.S53381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
60 Munyaka PM, Rabbi MF, Khafipour E, Ghia JE. Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice. J Basic Microbiol. 2016;56:986-998. [PMID: 27112251 DOI: 10.1002/jobm.201500726] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 15.8] [Reference Citation Analysis]
61 Anka Idrissi D, Senhaji N, Aouiss A, Khalki L, Tijani Y, Zaid N, Marhoume FZ, Naya A, Oudghiri M, Kabine M, Zaid Y. IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets. Arch Pharm Res 2021;44:117-32. [PMID: 33394309 DOI: 10.1007/s12272-020-01296-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol 2017; 23(33): 6016-6029 [PMID: 28970718 DOI: 10.3748/wjg.v23.i33.6016] [Cited by in CrossRef: 215] [Cited by in F6Publishing: 200] [Article Influence: 43.0] [Reference Citation Analysis]
63 Oh SJ, Seo Y, Ahn JS, Shin YY, Yang JW, Kim HK, Han J, Mishchenko NP, Fedoreyev SA, Stonik VA, Kim HS. Echinochrome A Reduces Colitis in Mice and Induces In Vitro Generation of Regulatory Immune Cells. Mar Drugs 2019;17:E622. [PMID: 31683521 DOI: 10.3390/md17110622] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
64 Algieri F, Rodriguez-Nogales A, Rodriguez-Cabezas ME, Risco S, Ocete MA, Galvez J. Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review. Mediators Inflamm. 2015;2015:179616. [PMID: 26576073 DOI: 10.1155/2015/179616] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
65 Park JS, Yi TG, Park JM, Han YM, Kim JH, Shin DH, Tak SJ, Lee K, Lee YS, Jeon MS. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. J Clin Biochem Nutr. 2015;57:192-203. [PMID: 26566304 DOI: 10.3164/jcbn.15-56] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
66 He X, Zhang QQ, Wang Z, Wang WZ, Wang LH. Chinese medicine enema for treatment of patients with mild to moderate ulcerative colitis: Therapeutic effect and regulatory effect on adiponectin. Shijie Huaren Xiaohua Zazhi 2015; 23(17): 2834-2838 [DOI: 10.11569/wcjd.v23.i17.2834] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Tomlinson ML, Butelli E, Martin C, Carding SR. Flavonoids from Engineered Tomatoes Inhibit Gut Barrier Pro-inflammatory Cytokines and Chemokines, via SAPK/JNK and p38 MAPK Pathways. Front Nutr 2017;4:61. [PMID: 29326940 DOI: 10.3389/fnut.2017.00061] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
68 Oladele JO, Anyim JC, Oyeleke OM, Olowookere BD, Bamigboye MO, Oladele OT, Oladiji AT. Telfairia occidentalis mitigates dextran sodium sulfate-induced ulcerative colitis in rats via suppression of oxidative stress, lipid peroxidation, and inflammation. J Food Biochem 2021;:e13873. [PMID: 34331468 DOI: 10.1111/jfbc.13873] [Reference Citation Analysis]
69 Li L, Miao X, Ni R, Miao X, Wang L, Gu X, Yan L, Tang Q, Zhang D. Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation. Immunol Res 2015;62:198-212. [DOI: 10.1007/s12026-015-8651-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
70 Zhang Y, Li F, Wang H, Yin C, Huang J, Mahavadi S, Murthy KS, Hu W. Immune/Inflammatory Response and Hypocontractility of Rabbit Colonic Smooth Muscle After TNBS-Induced Colitis. Dig Dis Sci 2016;61:1925-40. [PMID: 26879904 DOI: 10.1007/s10620-016-4078-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
71 Feng BS, Wu YJ, Zeng XH, Yu D, Liu ZQ, Zhou CJ, Liu ZG, Zheng PY, Yang PC. Bcl2L12 mediates effects of protease-activated receptor-2 on the pathogenesis of Th2-dominated responses of patients with ulcerative colitis. Arch Biochem Biophys 2018;657:8-14. [PMID: 30217509 DOI: 10.1016/j.abb.2018.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
72 Nong H, Huang X. Murine model of dextran sodium sulfate induced ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2014; 22(22): 3245-3250 [DOI: 10.11569/wcjd.v22.i22.3245] [Cited by in CrossRef: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Brunner SM, Reichmann F, Leitner J, Wölfl S, Bereswill S, Farzi A, Schneider AM, Klieser E, Neureiter D, Emberger M, Heimesaat MM, Weghuber D, Lang R, Holzer P, Kofler B. Galanin receptor 3 attenuates inflammation and influences the gut microbiota in an experimental murine colitis model. Sci Rep 2021;11:564. [PMID: 33436730 DOI: 10.1038/s41598-020-79456-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Kaur Bilkhoo H, Ducruet T, Marchand V, Deslandres C, Djemli A, Dal Soglio D, Patey N. Revisiting Pathological Criteria for Earlier Diagnosis of Coeliac Disease. Journal of Pediatric Gastroenterology & Nutrition 2016;62:734-8. [DOI: 10.1097/mpg.0000000000001026] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Slebioda TJ, Bojarska-Junak A, Cyman M, Landowski P, Kaminska B, Celinski K, Kmiec Z. Expression of death receptor 3 on peripheral blood mononuclear cells differes in adult IBD patients and children with newly diagnosed IBD. Cytometry B Clin Cytom 2017;92:165-9. [PMID: 27001939 DOI: 10.1002/cyto.b.21372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
76 Seong G, Kim N, Joung JG, Kim ER, Chang DK, Chun J, Hong SN, Kim YH. Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle. Microorganisms 2020;8:E874. [PMID: 32527024 DOI: 10.3390/microorganisms8060874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
77 Wang SL, Shao BZ, Zhao SB, Fang J, Gu L, Miao CY, Li ZS, Bai Y. Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease. Front Immunol 2018;9:693. [PMID: 29675025 DOI: 10.3389/fimmu.2018.00693] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
78 Xiuhong L, Yajun DU, Guoxing L, Guomei D, Xin T, Juan X. [Kirenol relieves dextran sulfate sodium-induced ulcerative colitis in mice by inhibiting inflammatory cytokines and inducing CD4+ T lymphocyte apoptosis]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1387-92. [PMID: 31907162 DOI: 10.12122/j.issn.1673-4254.2019.12.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Hyun CK. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:9139. [PMID: 34502047 DOI: 10.3390/ijms22179139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Deng Z, Cui C, Wang Y, Ni J, Zheng L, Wei H, Peng J. FSGHF3 and peptides, prepared from fish skin gelatin, exert a protective effect on DSS-induced colitis via the Nrf2 pathway. Food Funct 2020;11:414-23. [DOI: 10.1039/c9fo02165e] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 5.5] [Reference Citation Analysis]
81 Facco M, Cabrelle A, Calabrese F, Teramo A, Cinetto F, Carraro S, Martini V, Calzetti F, Tamassia N, Cassatella MA, Semenzato G, Agostini C. TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis. Clin Mol Allergy 2015;13:16. [PMID: 26240517 DOI: 10.1186/s12948-015-0022-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
82 Quiros M, Nishio H, Neumann PA, Siuda D, Brazil JC, Azcutia V, Hilgarth R, O'Leary MN, Garcia-Hernandez V, Leoni G, Feng M, Bernal G, Williams H, Dedhia PH, Gerner-Smidt C, Spence J, Parkos CA, Denning TL, Nusrat A. Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling. J Clin Invest 2017;127:3510-20. [PMID: 28783045 DOI: 10.1172/JCI90229] [Cited by in Crossref: 73] [Cited by in F6Publishing: 47] [Article Influence: 14.6] [Reference Citation Analysis]
83 Schnell A, Schwarz B, Wahlbuhl M, Allabauer I, Hess M, Weber S, Werner F, Schmidt H, Rechenauer T, Siebenlist G, Kaspar S, Ehrsam C, Rieger D, Rückel A, Metzler M, Christoph J, Woelfle J, Rascher W, Hoerning A. Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy. Inflamm Bowel Dis 2021;27:224-35. [PMID: 32185399 DOI: 10.1093/ibd/izaa054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Britzen-Laurent N, Herrmann C, Naschberger E, Croner RS, Stürzl M. Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases. World J Gastroenterol 2016; 22(28): 6434-6443 [PMID: 27605879 DOI: 10.3748/wjg.v22.i28.6434] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
85 Lim SM, Lee SY, Jeong JJ, Choi HS, Chang HB, Kim DH. DW2007 Ameliorates Colitis and Rheumatoid Arthritis in Mice by Correcting Th17/Treg Imbalance and Inhibiting NF-κB Activation. Biomol Ther (Seoul) 2016;24:638-49. [PMID: 27302961 DOI: 10.4062/biomolther.2016.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
86 Moura FA, de Andrade KQ, Dos Santos JCF, Araújo ORP, Goulart MOF. Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? Redox Biol 2015;6:617-39. [PMID: 26520808 DOI: 10.1016/j.redox.2015.10.006] [Cited by in Crossref: 175] [Cited by in F6Publishing: 158] [Article Influence: 25.0] [Reference Citation Analysis]
87 García-Cuesta EM, Santiago CA, Vallejo-Díaz J, Juarranz Y, Rodríguez-Frade JM, Mellado M. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases. Front Endocrinol (Lausanne) 2019;10:585. [PMID: 31507535 DOI: 10.3389/fendo.2019.00585] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
88 O'Dwyer AM, Lajczak NK, Keyes JA, Ward JB, Greene CM, Keely SJ. Ursodeoxycholic acid inhibits TNFα-induced IL-8 release from monocytes. Am J Physiol Gastrointest Liver Physiol 2016;311:G334-41. [PMID: 27340129 DOI: 10.1152/ajpgi.00406.2015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
89 Li LJ, Zeng L, Li XX, Mo LH, Geng XR, Zheng PY, Liu ZG, Feng BS, Yang PC. Induction of colitis in mice with food allergen-specific immune response. Sci Rep 2016;6:32765. [PMID: 27604348 DOI: 10.1038/srep32765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
90 Zhang M, Zhao Y, Wu N, Yao Y, Xu M, Du H, Tu Y. The anti-inflammatory activity of peptides from simulated gastrointestinal digestion of preserved egg white in DSS-induced mouse colitis. Food Funct 2018;9:6444-54. [PMID: 30462121 DOI: 10.1039/c8fo01939h] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
91 Ostrowski J, Dabrowska M, Lazowska I, Paziewska A, Balabas A, Kluska A, Kulecka M, Karczmarski J, Ambrozkiewicz F, Piatkowska M, Goryca K, Zeber-Lubecka N, Kierkus J, Socha P, Lodyga M, Klopocka M, Iwanczak B, Bak-Drabik K, Walkowiak J, Radwan P, Grzybowska-Chlebowczyk U, Korczowski B, Starzynska T, Mikula M. Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases. J Crohns Colitis. 2019;13:626-633. [PMID: 30541017 DOI: 10.1093/ecco-jcc/jjy205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
92 Mai P, Chen C, Xiao X, Ma X, Shi Y, Miao G, Zhang L. Rosmarinic acid protects against ulcerative colitis by regulating macrophage polarization depending on heme oxygenase-1 in mice. Eur J Inflamm 2020;18:205873922095991. [DOI: 10.1177/2058739220959916] [Reference Citation Analysis]
93 Goyal N, Rana A, Ahlawat A, Bijjem KR, Kumar P. Animal models of inflammatory bowel disease: a review. Inflammopharmacology. 2014;22:219-233. [PMID: 24906689 DOI: 10.1007/s10787-014-0207-y] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 12.9] [Reference Citation Analysis]
94 Agus A, Massier S, Darfeuille-Michaud A, Billard E, Barnich N. Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies. Biomed Res Int 2014;2014:567929. [PMID: 25580435 DOI: 10.1155/2014/567929] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
95 Irún P, Lanas A, Piazuelo E. Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review. Front Pharmacol 2019;10:852. [PMID: 31427966 DOI: 10.3389/fphar.2019.00852] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
96 Menchetti L, Curone G, Filipescu IE, Barbato O, Leonardi L, Guelfi G, Traina G, Casagrande-Proietti P, Riva F, Casano AB, Piro F, Vigo D, Quattrone A, Brecchia G. The Prophylactic Use of Bovine Colostrum in a Murine Model of TNBS-Induced Colitis. Animals (Basel) 2020;10:E492. [PMID: 32183497 DOI: 10.3390/ani10030492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
97 Lim SM, Choi HS, Jeong JJ, Han SW, Kim DH. The Rhizome Mixture of Anemarrhena asphodeloides and Coptis chinensis Attenuates Mesalazine-Resistant Colitis in Mice. Evid Based Complement Alternat Med 2016;2016:5895184. [PMID: 27761147 DOI: 10.1155/2016/5895184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
98 Berlec A, Perše M, Ravnikar M, Lunder M, Erman A, Cerar A, Štrukelj B. Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor α. Int Immunopharmacol 2017;43:219-26. [PMID: 28039805 DOI: 10.1016/j.intimp.2016.12.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
99 Kovacs SB, Sheikh V, Thompson WL, Morcock DR, Perez-Diez A, Yao MD, Rupert AW, Utay NS, Roby G, Freeman AF, Estes JD, Sereti I. T-Cell Depletion in the Colonic Mucosa of Patients With Idiopathic CD4+ Lymphopenia. J Infect Dis 2015;212:1579-87. [PMID: 25995198 DOI: 10.1093/infdis/jiv282] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
100 Mirsepasi-lauridsen HC, Vranckx K, Nielsen HV, Andersen LO, Archampong T, Krogfelt KA, Petersen AM. Substantial Intestinal Microbiota Differences Between Patients With Ulcerative Colitis From Ghana and Denmark. Front Cell Infect Microbiol 2022;12:832500. [DOI: 10.3389/fcimb.2022.832500] [Reference Citation Analysis]
101 Nag A, Romero B. Development and content validation of patient-reported outcomes tools for ulcerative colitis and Crohn's disease in adults with moderate-to-severe disease. Health Qual Life Outcomes 2022;20:75. [PMID: 35525935 DOI: 10.1186/s12955-022-01975-1] [Reference Citation Analysis]
102 Arafah K, Kriegsmann M, Renner M, Lasitschka F, Fresnais M, Kriegsmann K, von Winterfeld M, Goeppert B, Kriegsmann J, Casadonte R, Kazdal D, Bulet P, Longuespée R. Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease. Proteomics Clin Appl 2020;14:e1900110. [PMID: 32003543 DOI: 10.1002/prca.201900110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
103 Bi K, Zhang X, Chen W, Diao H. MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review. Genes (Basel) 2020;11:E1075. [PMID: 32932716 DOI: 10.3390/genes11091075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
104 Magalhães D, Cabral JM, Soares-da-Silva P, Magro F. Role of epithelial ion transports in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2016;310:G460-76. [PMID: 26744474 DOI: 10.1152/ajpgi.00369.2015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
105 Li Y, Zhang YY, Yang LT, Liu JQ, Zhou C, Liu ZQ, Yang G, Mo LH, Liu ZG, Feng BS, Yang PC. FcγRI plays a critical role in patients with ulcerative colitis relapse. Eur J Immunol 2021;51:459-70. [PMID: 33078845 DOI: 10.1002/eji.202048622] [Reference Citation Analysis]
106 Claudino RF, Leite DF, Bento AF, Chichorro JG, Calixto JB, Rae GA. Potential role for ET-2 acting through ETA receptors in experimental colitis in mice. Inflamm Res 2017;66:141-55. [PMID: 27778057 DOI: 10.1007/s00011-016-1001-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
107 Ibrahim SRM, Altyar AE, Sindi IA, El-Agamy DS, Abdallah HM, Mohamed SGA, Mohamed GA. Kirenol: A promising bioactive metabolite from siegesbeckia species: A detailed review. J Ethnopharmacol 2021;281:114552. [PMID: 34438028 DOI: 10.1016/j.jep.2021.114552] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Shin EJ, Sung MJ, Yang HJ, Kim MS, Hwang JT. Boehmeria nivea attenuates the development of dextran sulfate sodium-induced experimental colitis. Mediators Inflamm 2014;2014:231942. [PMID: 25045208 DOI: 10.1155/2014/231942] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
109 Yi JX, Fei SJ, Pang XL, Wu KJ. Therapeutic effects of curcumin combined with MSCs against ulcerative colitis in rats. Shijie Huaren Xiaohua Zazhi 2014; 22(12): 1642-1650 [DOI: 10.11569/wcjd.v22.i12.1642] [Reference Citation Analysis]
110 Klooster JPT, Bol-Schoenmakers M, van Summeren K, van Vliet ALW, de Haan CAM, van Kuppeveld FJM, Verkoeijen S, Pieters R. Enterocytes, fibroblasts and myeloid cells synergize in anti-bacterial and anti-viral pathways with IL22 as the central cytokine. Commun Biol 2021;4:631. [PMID: 34045640 DOI: 10.1038/s42003-021-02176-0] [Reference Citation Analysis]
111 Sun Q, Arif M, Chi Z, Li G, Liu CG. Macrophages-targeting mannosylated nanoparticles based on inulin for the treatment of inflammatory bowel disease (IBD). Int J Biol Macromol 2021;169:206-15. [PMID: 33340633 DOI: 10.1016/j.ijbiomac.2020.12.094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
112 Xie Y, Li D, Luan X, Jin S, Yan B, Tian F. Protective Effect of Thalidomide on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis in Rats via the Inhibition of T Helper 17 Cells. Can J Gastroenterol Hepatol 2020;2020:8861854. [PMID: 32766176 DOI: 10.1155/2020/8861854] [Reference Citation Analysis]
113 Livshits G, Kalinkovich A. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders. Pharmacol Res 2021;164:105340. [PMID: 33276103 DOI: 10.1016/j.phrs.2020.105340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Chen M, Gao L, Chen P, Feng D, Jiang Y, Chang Y, Jin J, Chu FF, Gao Q. Serotonin-Exacerbated DSS-Induced Colitis Is Associated with Increase in MMP-3 and MMP-9 Expression in the Mouse Colon. Mediators Inflamm 2016;2016:5359768. [PMID: 27478308 DOI: 10.1155/2016/5359768] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
115 Nishikawa H, Nakamura S, Miyazaki T, Kakimoto K, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Inflammatory Bowel Disease and Sarcopenia: Its Mechanism and Clinical Importance. J Clin Med 2021;10:4214. [PMID: 34575326 DOI: 10.3390/jcm10184214] [Reference Citation Analysis]
116 Thorlacius-Ussing G, Schnack Nielsen B, Andersen V, Holmstrøm K, Pedersen AE. Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:739-52. [PMID: 28426456 DOI: 10.1097/MIB.0000000000001086] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 6.8] [Reference Citation Analysis]
117 Palazzo L, Mikolčević P, Mikoč A, Ahel I. ADP-ribosylation signalling and human disease. Open Biol 2019;9:190041. [PMID: 30991935 DOI: 10.1098/rsob.190041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
118 Jiang L, Lv J, Liu J, Hao X, Ren F, Guo H. Donkey milk lysozyme ameliorates dextran sulfate sodium-induced colitis by improving intestinal barrier function and gut microbiota composition. Journal of Functional Foods 2018;48:144-52. [DOI: 10.1016/j.jff.2018.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
119 Ozma MA, Khodadadi E, Pakdel F, Kamounah FS, Yousefi M, Yousefi B, Asgharzadeh M, Ganbarov K, Kafil HS. Baicalin, a natural antimicrobial and anti-biofilm agent. Journal of Herbal Medicine 2021;27:100432. [DOI: 10.1016/j.hermed.2021.100432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
120 Nasser M, Haider A, Saad F, Kurtz W, Doros G, Fijak M, Vignozzi L, Gooren L. Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study. Horm Mol Biol Clin Investig 2015;22:111-7. [PMID: 26020563 DOI: 10.1515/hmbci-2015-0014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
121 Wyant T, Fedyk E, Abhyankar B. An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab. J Crohns Colitis. 2016;10:1437-1444. [PMID: 27252400 DOI: 10.1093/ecco-jcc/jjw092] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 13.5] [Reference Citation Analysis]
122 Zwicker S, Martinez GL, Bosma M, Gerling M, Clark R, Majster M, Söderman J, Almer S, Boström EA. Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. Clin Sci (Lond) 2015;129:281-90. [PMID: 25896238 DOI: 10.1042/CS20150176] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 7.6] [Reference Citation Analysis]
123 Wang L, Gao M, Kang G, Huang H. The Potential Role of Phytonutrients Flavonoids Influencing Gut Microbiota in the Prophylaxis and Treatment of Inflammatory Bowel Disease. Front Nutr 2021;8:798038. [PMID: 34970585 DOI: 10.3389/fnut.2021.798038] [Reference Citation Analysis]
124 Johnson TO, Odoh KD, Nwonuma CO, Akinsanmi AO, Adegboyega AE. Biochemical evaluation and molecular docking assessment of the anti-inflammatory potential of Phyllanthus nivosus leaf against ulcerative colitis. Heliyon 2020;6:e03893. [PMID: 32426537 DOI: 10.1016/j.heliyon.2020.e03893] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
125 Bakri FG, Wahbeh A, Abu Sneina A, Al Khader A, Obeidat F, AlAwwa I, Buni M, Ki CS, Masri A. Congenital insensitivity to pain and anhydrosis due to a rare mutation and that is complicated by inflammatory bowel disease and amyloidosis: a case report. Clin Case Rep 2016;4:997-1000. [PMID: 27761255 DOI: 10.1002/ccr3.689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
126 Sánchez-Fidalgo S, Villegas I, Aparicio-Soto M, Cárdeno A, Rosillo MÁ, González-Benjumea A, Marset A, López Ó, Maya I, Fernández-Bolaños JG, Alarcón de la Lastra C. Effects of dietary virgin olive oil polyphenols: hydroxytyrosyl acetate and 3, 4-dihydroxyphenylglycol on DSS-induced acute colitis in mice. J Nutr Biochem 2015;26:513-20. [PMID: 25736481 DOI: 10.1016/j.jnutbio.2014.12.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
127 Polytarchou C, Koukos G, Iliopoulos D. Systems biology in inflammatory bowel diseases: ready for prime time. Curr Opin Gastroenterol 2014;30:339-46. [PMID: 24837229 DOI: 10.1097/MOG.0000000000000081] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
128 Eun SH, Lim SM, Jang SE, Han MJ, Kim DH. Lactobacillus sakei K17, an inducer of IL-10 expression in antigen-presenting cells, attenuates TNBS-induced colitis in mice. Immunopharmacol Immunotoxicol 2016;38:447-54. [PMID: 27600362 DOI: 10.1080/08923973.2016.1233981] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
129 Holleran G, Lopetuso L, Petito V, Graziani C, Ianiro G, McNamara D, Gasbarrini A, Scaldaferri F. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. Int J Mol Sci. 2017;18. [PMID: 28934123 DOI: 10.3390/ijms18102020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
130 Sáez-gonzález E, Moret I, Alvarez-sotomayor D, Díaz-jaime FC, Cerrillo E, Iborra M, Nos P, Beltrán B. Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease. Dig Dis Sci 2017;62:1417-25. [DOI: 10.1007/s10620-017-4577-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
131 Leccese G, Bibi A, Mazza S, Facciotti F, Caprioli F, Landini P, Paroni M. Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis, but Not in Crohn's Disease. Cells 2020;9:E1824. [PMID: 32752244 DOI: 10.3390/cells9081824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
132 Principi M, Labarile N, Bianchi FP, Contaldo A, Tafuri S, Ierardi E, Di Leo A. The Cost of Inflammatory Bowel Disease Management Matches with Clinical Course: A Single Outpatient Centre Analysis. Int J Environ Res Public Health 2020;17:E4549. [PMID: 32599816 DOI: 10.3390/ijerph17124549] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Li P, Shi J, Zhang P, Wang K, Li J, Liu H, Zhou Y, Xu X, Hao J, Sun X, Pang X, Li Y, Wu H, Chen X, Ge Q. Simulated microgravity disrupts intestinal homeostasis and increases colitis susceptibility. FASEB J 2015;29:3263-73. [PMID: 25877215 DOI: 10.1096/fj.15-271700] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
134 Yang R, Gao H, Chen L, Fang N, Chen H, Song G, Yu L, Zhang Q, Zhang T. Effect of peripheral blood-derived mesenchymal stem cells on macrophage polarization and Th17/Treg balance in vitro. Regen Ther 2020;14:275-83. [PMID: 32455158 DOI: 10.1016/j.reth.2020.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
135 Liu F, Liu J, Wang TTY, Liu Z, Xue C, Mao X, Tang Q, Li RW. Molecular and Microbial Signatures Predictive of Prebiotic Action of Neoagarotetraose in a Dextran Sulfate Sodium-Induced Murine Colitis Model. Microorganisms 2020;8:E995. [PMID: 32635315 DOI: 10.3390/microorganisms8070995] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Samoilă I, Dinescu S, Costache M. Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development-A Focus on Ulcerative Colitis. Cells 2020;9:E1647. [PMID: 32659925 DOI: 10.3390/cells9071647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
137 Okba AM, Amin MM, Abdelmoaty AS, Ebada HE, Kamel AH, Allam AS, Sobhy OM. Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity. Auto Immun Highlights 2019;10:4. [PMID: 32257060 DOI: 10.1186/s13317-019-0114-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
138 Matsunaga Y, Hasei S, Yamamotoya T, Honda H, Kushiyama A, Sakoda H, Fujishiro M, Ono H, Ito H, Okabe T, Asano T, Nakatsu Y. Pathological Role of Pin1 in the Development of DSS-Induced Colitis. Cells 2021;10:1230. [PMID: 34067858 DOI: 10.3390/cells10051230] [Reference Citation Analysis]
139 Zhang H, Ta N, Shen H, Wang H. Effects of Jian Pi Qing Chang Hua Shi decoction on mucosal injuries in a 2,4,6-trinitrobenzene sulphonic acid-induced inflammatory bowel disease rat model. Pharm Biol 2021;59:683-95. [PMID: 34110957 DOI: 10.1080/13880209.2021.1928240] [Reference Citation Analysis]
140 Ghaly S, Lawrance I. The role of vitamin D in gastrointestinal inflammation. Expert Review of Gastroenterology & Hepatology 2014;8:909-23. [DOI: 10.1586/17474124.2014.925796] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
141 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
142 Amarasekara DS, Yu J, Rho J. Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases. J Immunol Res 2015;2015:832127. [PMID: 26065006 DOI: 10.1155/2015/832127] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
143 Guo X, Guo R, Luo X, Zhou L. Ethyl pyruvate ameliorates experimental colitis in mice by inhibiting the HMGB1-Th17 and Th1/Tc1 responses. International Immunopharmacology 2015;29:454-61. [DOI: 10.1016/j.intimp.2015.10.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
144 Schwanke RC, Marcon R, Bento AF, Calixto JB. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease. Eur J Pharmacol 2016;785:156-64. [PMID: 26325092 DOI: 10.1016/j.ejphar.2015.08.050] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
145 Zammit SC, Cachia M, Sapiano K, Gauci J, Montefort S, Ellul P. Eosinophilic gastrointestinal disorder: is it what it seems to be? Ann Gastroenterol 2018;31:475-9. [PMID: 29991893 DOI: 10.20524/aog.2018.0263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
146 Jiao Q, Luo Y, Scheffel J, Zhao Z, Maurer M. The complex role of mast cells in fungal infections. Exp Dermatol 2019;28:749-55. [DOI: 10.1111/exd.13907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
147 Chen YH, Liu RH, Cui YZ, Hettinghouse A, Fu WY, Zhang L, Zhang C, Liu CJ. Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases. Arthritis Res Ther 2022;24:27. [PMID: 35045889 DOI: 10.1186/s13075-021-02713-6] [Reference Citation Analysis]
148 Sakurai T, Okuyama Y, Kobayashi S, Phung HT, Asao A, Kawabe T, Ndhlovu LC, Riccardi C, Kudo H, Wada M, Nio M, So T, Ishii N. GITR controls intestinal inflammation by suppressing IL-15-dependent NK cell activity. FASEB J 2020;34:14820-31. [PMID: 32910505 DOI: 10.1096/fj.202001675R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Jia Y, Anwaar S, Li L, Yin Z, Ye Z, Huang Z. A new target for the treatment of inflammatory bowel disease: Interleukin-37. Int Immunopharmacol 2020;83:106391. [PMID: 32208166 DOI: 10.1016/j.intimp.2020.106391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
150 Liu J, Wang HW, Lin L, Miao CY, Zhang Y, Zhou BH. Intestinal barrier damage involved in intestinal microflora changes in fluoride-induced mice. Chemosphere 2019;234:409-18. [PMID: 31228844 DOI: 10.1016/j.chemosphere.2019.06.080] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
151 Sarazin A, Dendooven A, Delbeke M, Gatault S, Pagny A, Standaert A, Rousseaux C, Desreumaux P, Dubuquoy L, Capron M. Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses. PLoS One 2018;13:e0209681. [PMID: 30592734 DOI: 10.1371/journal.pone.0209681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
152 Pavlidis S, Monast C, Loza MJ, Branigan P, Chung KF, Adcock IM, Guo Y, Rowe A, Baribaud F. I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. PLoS Comput Biol 2019;15:e1006951. [PMID: 31039157 DOI: 10.1371/journal.pcbi.1006951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
153 Fernández-tomé S, Montalban-arques A, Díaz-guerra A, Galvan-roman JM, Marin AC, Mora-gutiérrez I, Ortega Moreno L, Santander C, Sánchez B, Chaparro M, Gisbert JP, Bernardo D. Peptides encrypted in the human intestinal microbial-exoproteome as novel biomarkers and immunomodulatory compounds in the gastrointestinal tract. Journal of Functional Foods 2019;52:459-68. [DOI: 10.1016/j.jff.2018.11.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
154 Tian Y, Zhang D, Nakamura M. Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier. Gastroenterology Research and Practice 2022;2022:1-11. [DOI: 10.1155/2022/2939921] [Reference Citation Analysis]
155 Chang YL, Lo HY, Cheng SP, Chang KT, Lin XF, Lee SP, Hsieh MF, Chan CK. Therapeutic effects of a single injection of human umbilical mesenchymal stem cells on acute and chronic colitis in mice. Sci Rep 2019;9:5832. [PMID: 30967579 DOI: 10.1038/s41598-019-41910-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
156 Busbee PB, Menzel L, Alrafas HR, Dopkins N, Becker W, Miranda K, Tang C, Chatterjee S, Singh U, Nagarkatti M, Nagarkatti PS. Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner. JCI Insight 2020;5:127551. [PMID: 31941837 DOI: 10.1172/jci.insight.127551] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
157 Holgersen K, Dobie R, Farquharson C, van’t Hof R, Ahmed SF, Hansen AK, Holm TL. Piroxicam treatment augments bone abnormalities in interleukin-10 knockout mice. Inflamm Bowel Dis. 2015;21:257-266. [PMID: 25569742 DOI: 10.1097/mib.0000000000000269] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
158 Obremski K, Trybowski W, Wojtacha P, Gajęcka M, Tyburski J, Zielonka Ł. The Effect of Zearalenone on the Cytokine Environment, Oxidoreductive Balance and Metabolism in Porcine Ileal Peyer's Patches. Toxins (Basel) 2020;12:E350. [PMID: 32471145 DOI: 10.3390/toxins12060350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Menghini P, Corridoni D, Buttó LF, Osme A, Shivaswamy S, Lam M, Bamias G, Pizarro TT, Rodriguez-Palacios A, Dinarello CA, Cominelli F. Neutralization of IL-1α ameliorates Crohn's disease-like ileitis by functional alterations of the gut microbiome. Proc Natl Acad Sci U S A 2019:201915043. [PMID: 31843928 DOI: 10.1073/pnas.1915043116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
160 Collins FL, Schepper JD, Rios-Arce ND, Steury MD, Kang HJ, Mallin H, Schoenherr D, Camfield G, Chishti S, McCabe LR, Parameswaran N. Immunology of Gut-Bone Signaling. Adv Exp Med Biol 2017;1033:59-94. [PMID: 29101652 DOI: 10.1007/978-3-319-66653-2_5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
161 Schoultz I, Keita ÅV. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function. Cells 2019;8:E193. [PMID: 30813280 DOI: 10.3390/cells8020193] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 17.0] [Reference Citation Analysis]
162 Baranowska-Nowak M, IwaŃczak B, Szczepanik M, Banasiuk M, DembiŃski Ł, Karolewska-Bochenek K, Dziekiewicz M, Radzikowski A, Banaszkiewicz A. Immune response to hepatitis B vaccination in pediatric patients with inflammatory bowel disease. Cent Eur J Immunol 2020;45:144-50. [PMID: 33456324 DOI: 10.5114/ceji.2020.97902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Ahmad T, Eapen MS, Ishaq M, Park AY, Karpiniec SS, Stringer DN, Sohal SS, Fitton JH, Guven N, Caruso V, Eri R. Anti-Inflammatory Activity of Fucoidan Extracts In Vitro. Marine Drugs 2021;19:702. [DOI: 10.3390/md19120702] [Reference Citation Analysis]
164 Coskun A, Yavasoglu I, Meteoglu I, Unubol M, Yasar B, Borazan S, Omurlu IK, Yukselen V, Yasa MH. Vitamin D Receptor Level in Biopsy Specimen of Patients with Ulcerative Colitis: Results from a Center in Western Anatolia. J Natl Med Assoc. 2018;110:276-280. [PMID: 29778131 DOI: 10.1016/j.jnma.2017.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
165 Li M, Liu X, Liu Z, Hong J, Liu J, Zhou C, Hu T, Xiao X, Ran P, Zheng P, Liu Z, Yang P. Bcl2L12 Contributes to Th2-Biased Inflammation in the Intestinal Mucosa by Regulating CD4 + T Cell Activities. J I 2018;201:725-33. [DOI: 10.4049/jimmunol.1800139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
166 Banfield C, Rudin D, Bhattacharya I, Goteti K, Li G, Hassan-Zahraee M, Brown LS, Hung KE, Pawlak S, Lepsy C. First-in-human, randomized dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF-06480605 in healthy subjects. Br J Clin Pharmacol 2020;86:812-24. [PMID: 31758576 DOI: 10.1111/bcp.14187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
167 Chaudhary CL, Chaudhary P, Dahal S, Bae D, Nam TG, Kim JA, Jeong BS. Inhibition of colitis by ring-modified analogues of 6-acetamido-2,4,5-trimethylpyridin-3-ol. Bioorg Chem 2020;103:104130. [PMID: 32745758 DOI: 10.1016/j.bioorg.2020.104130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
168 Mishra R, Dhawan P, Srivastava AS, Singh AB. Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy. World J Stem Cells 2020; 12(10): 1050-1066 [PMID: 33178391 DOI: 10.4252/wjsc.v12.i10.1050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
169 Ahluwalia B, Moraes L, Magnusson MK, Öhman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol 2018;53:379-89. [PMID: 29523023 DOI: 10.1080/00365521.2018.1447597] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 14.5] [Reference Citation Analysis]
170 Machado FDF, Formiga RO, Lima GRM, de Jesus NZT, Alves Júnior EB, Marinho AF, Tavares JF, Santos FA, Viana AFSC, Araújo AA, de Araújo Júnior RF, Pellizzon CH, Batista LM. Hyptis suaveolens (L.) Poit protects colon from TNBS-induced inflammation via immunomodulatory, antioxidant and anti-proliferative mechanisms. J Ethnopharmacol 2021;265:113153. [PMID: 32702379 DOI: 10.1016/j.jep.2020.113153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Defaye M, Gervason S, Altier C, Berthon JY, Ardid D, Filaire E, Carvalho FA. Microbiota: a novel regulator of pain. J Neural Transm (Vienna) 2020;127:445-65. [PMID: 31552496 DOI: 10.1007/s00702-019-02083-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
172 Meeker S, Seamons A, Maggio-Price L, Paik J. Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol 2016; 22(3): 933-948 [PMID: 26811638 DOI: 10.3748/wjg.v22.i3.933] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 58] [Article Influence: 11.7] [Reference Citation Analysis]
173 Quetglas EG, Mujagic Z, Wigge S, Keszthelyi D, Wachten S, Masclee A, Reinisch W. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World J Gastroenterol 2015; 21(44): 12519-12543 [PMID: 26640330 DOI: 10.3748/wjg.v21.i44.12519] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
174 Kang GD, Kim DH. Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance. J Ethnopharmacol. 2016;189:175-185. [PMID: 27224242 DOI: 10.1016/j.jep.2016.05.044] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
175 Hiramoto K, Yamate Y, Sato EF. The Effects of Ultraviolet Eye Irradiation on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice. Photochem Photobiol 2016;92:728-34. [DOI: 10.1111/php.12620] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
176 Modi NB, Cheng X, Mattheakis L, Hwang CC, Nawabi R, Liu D, Gupta S. Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers. Clin Pharmacol Drug Dev 2021. [PMID: 33942566 DOI: 10.1002/cpdd.946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
177 De Cicco P, Sanders T, Cirino G, Maloy KJ, Ianaro A. Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of Helicobacter hepaticus-Induced Colitis. Front Immunol 2018;9:499. [PMID: 29636751 DOI: 10.3389/fimmu.2018.00499] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
178 Si X, Liu N, Jia H, Wang J, Pan L, Dong L, Rong Z, Yang Y, Wu Z. Gut relief formula attenuates dextran sulfate sodium-induced colitis by regulating NF-κB signaling and the intestinal microbiota in mice. Food Funct 2021;12:10983-93. [PMID: 34652352 DOI: 10.1039/d1fo01477c] [Reference Citation Analysis]
179 Filipescu IE, Leonardi L, Menchetti L, Guelfi G, Traina G, Casagrande-Proietti P, Piro F, Quattrone A, Barbato O, Brecchia G. Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice. PLoS One 2018;13:e0202929. [PMID: 30138385 DOI: 10.1371/journal.pone.0202929] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
180 Assadsangabi A, Evans CA, Corfe BM, Lobo A. Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives. Gastroenterol Res Pract 2019;2019:1426954. [PMID: 30774653 DOI: 10.1155/2019/1426954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
181 Prosberg M, Bendtsen F, Vind I, Petersen AM, Gluud LL. The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis. Scand J Gastroenterol. 2016;51:1407-1415. [PMID: 27687331 DOI: 10.1080/00365521.2016.1216587] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 14.7] [Reference Citation Analysis]
182 Shen NY, Bi JB, Zhang JY, Zhang SM, Gu JX, Qu K, Liu C. Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression. World J Gastroenterol 2017; 23(8): 1375-1386 [PMID: 28293084 DOI: 10.3748/wjg.v23.i8.1375] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
183 Wang Z, Adachi S, Kong L, Watanabe D, Nakanishi Y, Ohteki T, Hoshi N, Kodama Y. Role of eosinophils in a murine model of inflammatory bowel disease. Biochemical and Biophysical Research Communications 2019;511:99-104. [DOI: 10.1016/j.bbrc.2019.02.056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
184 Zhou M, He J, Shen Y, Zhang C, Wang J, Chen Y. New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease. Biomed Res Int 2017;2017:8201672. [PMID: 28831399 DOI: 10.1155/2017/8201672] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
185 Li H, Song J, Niu G, Zhang H, Guo J, Shih DQ, Targan SR, Zhang X. TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice. Pathol Res Pract 2018;214:217-27. [PMID: 29254800 DOI: 10.1016/j.prp.2017.11.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
186 Pisani LF, Moriggi M, Gelfi C, Vecchi M, Pastorelli L. Proteomic insights on the metabolism in inflammatory bowel disease. World J Gastroenterol 2020; 26(7): 696-705 [PMID: 32116417 DOI: 10.3748/wjg.v26.i7.696] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Dos Santos Ramos A, Viana GCS, de Macedo Brigido M, Almeida JF. Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets. Pharmacol Res 2021;171:105779. [PMID: 34298111 DOI: 10.1016/j.phrs.2021.105779] [Reference Citation Analysis]
188 Pouya S, Heidari M, Baghaei K, Asadzadeh Aghdaei H, Moradi A, Namaki S, Zali MR, Hashemi SM. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol. 2018;54:86-94. [PMID: 29112894 DOI: 10.1016/j.intimp.2017.11.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
189 Jones GR, Bain CC, Fenton TM, Kelly A, Brown SL, Ivens AC, Travis MA, Cook PC, MacDonald AS. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764. [PMID: 30542349 DOI: 10.3389/fimmu.2018.02764] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
190 Fu SH, Chien MW, Hsu CY, Liu YW, Sytwu HK. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E3379. [PMID: 32403220 DOI: 10.3390/ijms21093379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
191 Ke K, Arra M, Abu-Amer Y. Mechanisms Underlying Bone Loss Associated with Gut Inflammation. Int J Mol Sci 2019;20:E6323. [PMID: 31847438 DOI: 10.3390/ijms20246323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
192 Haga K, Chiba A, Shibuya T, Osada T, Ishikawa D, Kodani T, Nomura O, Watanabe S, Miyake S. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis. J Gastroenterol Hepatol 2016;31:965-72. [PMID: 26590105 DOI: 10.1111/jgh.13242] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 13.0] [Reference Citation Analysis]
193 Choy MC, Visvanathan K, De Cruz P. An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2017;23:2-13. [DOI: 10.1097/mib.0000000000000955] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
194 Kmieć Z, Cyman M, Ślebioda TJ. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv Med Sci 2017;62:1-16. [PMID: 28126697 DOI: 10.1016/j.advms.2016.09.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 10.6] [Reference Citation Analysis]
195 Scarano A, Chieppa M, Santino A. Plant Polyphenols-Biofortified Foods as a Novel Tool for the Prevention of Human Gut Diseases. Antioxidants (Basel) 2020;9:E1225. [PMID: 33287404 DOI: 10.3390/antiox9121225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
196 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
197 Barreto de Albuquerque J, Mueller C, Gungor B. Tissue-Resident T Cells in Chronic Relapsing-Remitting Intestinal Disorders. Cells 2021;10:1882. [PMID: 34440651 DOI: 10.3390/cells10081882] [Reference Citation Analysis]
198 Gulledge TV, Collette NM, Mackey E, Johnstone SE, Moazami Y, Todd DA, Moeser AJ, Pierce JG, Cech NB, Laster SM. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide. J Ethnopharmacol 2018;212:166-74. [PMID: 29042288 DOI: 10.1016/j.jep.2017.10.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
199 Dunn ET, Taylor ES, Stebbings S, Schultz M, Butt AG, Kemp RA. Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation. Immunol Cell Biol 2016;94:421-9. [PMID: 26647966 DOI: 10.1038/icb.2015.112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
200 de Paula-Silva M, Barrios BE, Macció-Maretto L, Sena AA, Farsky SH, Correa SG, Oliani SM. Role of the protein annexin A1 on the efficacy of anti-TNF treatment in a murine model of acute colitis. Biochem Pharmacol 2016;115:104-13. [PMID: 27343762 DOI: 10.1016/j.bcp.2016.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
201 Vester-Andersen MK, Mirsepasi-Lauridsen HC, Prosberg MV, Mortensen CO, Träger C, Skovsen K, Thorkilgaard T, Nøjgaard C, Vind I, Krogfelt KA, Sørensen N, Bendtsen F, Petersen AM. Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis. Sci Rep 2019;9:13473. [PMID: 31530835 DOI: 10.1038/s41598-019-49833-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
202 Haag LM, Siegmund B. Intestinal microbiota and the innate immune system - A crosstalk in crohn's disease pathogenesis. Front Immunol. 2015;6:489. [PMID: 26441993 DOI: 10.3389/fimmu.2015.00489] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
203 Schoultz I, Keita ÅV. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells 2020;9:E1909. [PMID: 32824536 DOI: 10.3390/cells9081909] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
204 Zhang T, Cui B, Li P, He Z, Long C, Wei L, Peng Z, Ji G, Zhang F. Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis. PLoS One 2016;11:e0158227. [PMID: 27347881 DOI: 10.1371/journal.pone.0158227] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
205 Moriichi K, Fujiya M, Okumura T. The endoscopic diagnosis of mucosal healing and deep remission in inflammatory bowel disease. Dig Endosc 2021;33:1008-23. [PMID: 33020947 DOI: 10.1111/den.13863] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
207 May RD, Fung M. Strategies targeting the IL-4/IL-13 axes in disease. Cytokine. 2015;75:89-116. [PMID: 26255210 DOI: 10.1016/j.cyto.2015.05.018] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 14.7] [Reference Citation Analysis]
208 Connelly TM, Koltun WA. Inflammatory Bowel Disease: Pathobiology. In: Steele SR, Hull TL, Read TE, Saclarides TJ, Senagore AJ, Whitlow CB, editors. The ASCRS Textbook of Colon and Rectal Surgery. Cham: Springer International Publishing; 2016. pp. 749-69. [DOI: 10.1007/978-3-319-25970-3_44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
209 Yousefi‐ahmadipour A, Rashidian A, Mirzaei MR, Farsinejad A, Pourmohammadi‐nejad F, Ghazi‐khansari M, Ai J, Shirian S, Allahverdi A, Saremi J, Ebrahimi‐barough S. Combination therapy of mesenchymal stromal cells and sulfasalazine attenuates trinitrobenzene sulfonic acid induced colitis in the rat: The S1P pathway. J Cell Physiol 2019;234:11078-91. [DOI: 10.1002/jcp.27944] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
210 Iwańczak B, Ruczka M, Matusiewicz M, Pytrus T, Matusiewicz K, Krzesiek E. Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children. Adv Med Sci 2020;65:259-64. [PMID: 32361483 DOI: 10.1016/j.advms.2020.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
211 Furukawa S, Ikeda Y, Yagi S, Miyake T, Shiraishi K, Tange K, Hashimoto Y, Mori K, Ninomiya T, Suzuki S, Shibata N, Murakami H, Ohashi K, Hasebe A, Tomida H, Yamamoto Y, Takeshita E, Hiasa Y. Association Between Peripheral Blood Monocyte Count and Mucosal Healing in Japanese Patients With Ulcerative Colitis. Clin Transl Gastroenterol 2021;12:e00429. [PMID: 34797817 DOI: 10.14309/ctg.0000000000000429] [Reference Citation Analysis]
212 Zhao L, Xiong Q, Stary CM, Mahgoub OK, Ye Y, Gu L, Xiong X, Zhu S. Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke. J Neuroinflammation 2018;15:339. [PMID: 30537997 DOI: 10.1186/s12974-018-1382-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
213 Choo J, Heo G, Pothoulakis C, Im E. Posttranslational modifications as therapeutic targets for intestinal disorders. Pharmacol Res 2021;165:105412. [PMID: 33412276 DOI: 10.1016/j.phrs.2020.105412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Alfwuaires MA, Algefare AI, Afkar E, Salam SA, El-Moaty HIA, Badr GM. Immunomodulatory assessment of Portulaca oleracea L. extract in a mouse model of colitis. Biomed Pharmacother 2021;143:112148. [PMID: 34560553 DOI: 10.1016/j.biopha.2021.112148] [Reference Citation Analysis]
215 Han F, Song J, Jia W, Yang M, Wang D, Zhang H, Shih DQ, Targan SR, Zhang X. TL1A primed dendritic cells activation exacerbated chronic murine colitis. Life Sci 2020;262:118220. [PMID: 32781075 DOI: 10.1016/j.lfs.2020.118220] [Reference Citation Analysis]
216 Sales-Campos H, de Souza PR, Basso PJ, Ramos AD, Nardini V, Chica JE, Capurro ML, Sá-Nunes A, de Barros Cardoso CR. Aedes aegypti salivary gland extract ameliorates experimental inflammatory bowel disease. Int Immunopharmacol 2015;26:13-22. [PMID: 25770821 DOI: 10.1016/j.intimp.2015.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
217 Paul J, Singh AK, Kathania M, Elviche TL, Zeng M, Basrur V, Theiss AL, Venuprasad K. IL-17-driven intestinal fibrosis is inhibited by Itch-mediated ubiquitination of HIC-5. Mucosal Immunol 2018;11:427-36. [PMID: 28612841 DOI: 10.1038/mi.2017.53] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
218 Aksan A, Tugal D, Hein N, Boettger K, Caicedo-Zea Y, Diehl I, Schumann C, Armbruster FP, Stein J. Measuring Vitamin D Status in Chronic Inflammatory Disorders: How does Chronic Inflammation Affect the Reliability of Vitamin D Metabolites in Patients with IBD? J Clin Med 2020;9:E547. [PMID: 32079317 DOI: 10.3390/jcm9020547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
219 Vecchi Brumatti L, Marcuzzi A, Tricarico PM, Zanin V, Girardelli M, Bianco AM. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules. 2014;19:21127-21153. [PMID: 25521115 DOI: 10.3390/molecules191221127] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 8.8] [Reference Citation Analysis]
220 Wang Y, Ren R, Sun G, Peng L, Tian Y, Yang Y. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. Int Immunopharmacol 2020;85:106661. [PMID: 32563025 DOI: 10.1016/j.intimp.2020.106661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
221 Al-Araimi A, Al Kindi IA, Bani Oraba A, AlKharusi A, Ali BH, Zadjali R, Al Sinawi S, Al-Haddabi I, Zadjali F. Gum Arabic Supplementation Suppresses Colonic Fibrosis After Acute Colitis by Reducing Transforming Growth Factor β1 Expression. J Med Food 2021. [PMID: 34704833 DOI: 10.1089/jmf.2021.0007] [Reference Citation Analysis]
222 Komaki S, Haque A, Miyazaki H, Matsumoto T, Nakamura S. Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice. J Infect Chemother 2020;26:549-53. [PMID: 32122783 DOI: 10.1016/j.jiac.2020.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Cai Y, Xu B, Zhou F, Wu J, Li S, Zheng Q, Li Y, Li X, Gao F, Dong S, Liu R. Si-Ni-San ameliorates chronic colitis by modulating type I interferons-mediated inflammation. Phytomedicine 2021;84:153495. [PMID: 33611210 DOI: 10.1016/j.phymed.2021.153495] [Reference Citation Analysis]
224 Caviglia GP, Rosso C, Stalla F, Rizzo M, Massano A, Abate ML, Olivero A, Armandi A, Vanni E, Younes R, Fagoonee S, Pellicano R, Astegiano M, Saracco GM, Bugianesi E, Ribaldone DG. On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. J Clin Med 2020;9:E800. [PMID: 32183476 DOI: 10.3390/jcm9030800] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
225 Ghaly S, Hart PH, Lawrance IC. Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome. Expert Rev Gastroenterol Hepatol 2019;13:1039-48. [PMID: 31657973 DOI: 10.1080/17474124.2019.1685874] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
226 Igarashi H, Ohno K, Horigome A, Fujiwara-Igarashi A, Kanemoto H, Fukushima K, Odamaki T, Tsujimoto H. Fecal dysbiosis in miniature dachshunds with inflammatory colorectal polyps. Res Vet Sci 2016;105:41-6. [PMID: 27033906 DOI: 10.1016/j.rvsc.2016.01.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
227 Wu Z, Bi Y. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients. J Clin Lab Anal 2022;:e24130. [PMID: 34997981 DOI: 10.1002/jcla.24130] [Reference Citation Analysis]
228 Bu Y, Wu H, Deng R, Wang Y. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases. Front Pharmacol 2021;12:733387. [PMID: 34737701 DOI: 10.3389/fphar.2021.733387] [Reference Citation Analysis]
229 Irving PM, de Lusignan S, Tang D, Nijher M, Barrett K. Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ Open Gastroenterol 2021;8:e000573. [PMID: 33597152 DOI: 10.1136/bmjgast-2020-000573] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
230 Shi J, Wang Y, He J, Li P, Jin R, Wang K, Xu X, Hao J, Zhang Y, Liu H, Chen X, Wu H, Ge Q. Intestinal microbiota contributes to colonic epithelial changes in simulated microgravity mouse model. FASEB J 2017;31:3695-709. [PMID: 28495755 DOI: 10.1096/fj.201700034R] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
231 Takagi T, Naito Y, Tanaka M, Mizushima K, Ushiroda C, Toyokawa Y, Uchiyama K, Hamaguchi M, Handa O, Itoh Y. Carbon monoxide ameliorates murine T-cell-dependent colitis through the inhibition of Th17 differentiation. Free Radic Res 2018;52:1328-35. [PMID: 29695203 DOI: 10.1080/10715762.2018.1470327] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
232 Besson JCF, de Carvalho Picoli C, Matioli G, Natali MRM. Methyl jasmonate: a phytohormone with potential for the treatment of inflammatory bowel diseases. J Pharm Pharmacol 2018;70:178-90. [PMID: 29072315 DOI: 10.1111/jphp.12839] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
233 Petagna L, Antonelli A, Ganini C, Bellato V, Campanelli M, Divizia A, Efrati C, Franceschilli M, Guida AM, Ingallinella S, Montagnese F, Sensi B, Siragusa L, Sica GS. Pathophysiology of Crohn's disease inflammation and recurrence. Biol Direct 2020;15:23. [PMID: 33160400 DOI: 10.1186/s13062-020-00280-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
234 Magalhães D, Soares-da-silva P, Magro F. The effect of PRR ligands on the membrane potential of intestinal epithelial cells. Pharmacological Reports 2017;69:978-84. [DOI: 10.1016/j.pharep.2017.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
235 Balmus IM, Ciobica A, Trifan A, Stanciu C. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models. Saudi J Gastroenterol. 2016;22:3-17. [PMID: 26831601 DOI: 10.4103/1319-3767.173753] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 20.8] [Reference Citation Analysis]
236 Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, García F, Rodríguez-Cabezas ME, Gálvez J. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition. J Nutr Biochem 2018;61:129-39. [PMID: 30236870 DOI: 10.1016/j.jnutbio.2018.08.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
237 Masu Y, Kanazawa Y, Kakuta Y, Shimoyama Y, Onodera M, Naito T, Moroi R, Kuroha M, Kimura T, Shiga H, Kinouchi Y, Masamune A. Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease. Sci Rep 2021;11:16672. [PMID: 34404881 DOI: 10.1038/s41598-021-96289-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Tian X, Tang L, Wei F, Chen H, Sheng L, Yang Y, Zhou X, Li Y, Xu X, Zhang B, Liu Z, Lei Y, Yu B, Bai C, He X, Huang Z. Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells. Mol Immunol 2021;132:30-40. [PMID: 33540227 DOI: 10.1016/j.molimm.2021.01.019] [Reference Citation Analysis]
239 Pierdominici M, Maselli A, Varano B, Barbati C, Cesaro P, Spada C, Zullo A, Lorenzetti R, Rosati M, Rainaldi G, Limiti MR, Guidi L, Conti L, Gessani S. Linking estrogen receptor β expression with inflammatory bowel disease activity. Oncotarget 2015;6:40443-51. [PMID: 26497217 DOI: 10.18632/oncotarget.6217] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
240 Abbasi-Kenarsari H, Heidari N, Baghaei K, Amani D, Zali MR, Gaffari Khaligh S, Shafiee A, Hashemi SM. Synergistic therapeutic effect of mesenchymal stem cells and tolerogenic dendritic cells in an acute colitis mouse model. Int Immunopharmacol 2020;88:107006. [PMID: 33182049 DOI: 10.1016/j.intimp.2020.107006] [Reference Citation Analysis]
241 Yang B, Li M, Wang S, Ross RP, Stanton C, Zhao J, Zhang H, Chen W. Lactobacillus ruminis Alleviates DSS-Induced Colitis by Inflammatory Cytokines and Gut Microbiota Modulation. Foods 2021;10:1349. [PMID: 34208038 DOI: 10.3390/foods10061349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Zarepoor L, Lu JT, Zhang C, Wu W, Lepp D, Robinson L, Wanasundara J, Cui S, Villeneuve S, Fofana B, Tsao R, Wood GA, Power KA. Dietary flaxseed intake exacerbates acute colonic mucosal injury and inflammation induced by dextran sodium sulfate. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014;306:G1042-55. [DOI: 10.1152/ajpgi.00253.2013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
243 Cagol L, Seitel T, Ehrenberg S, Frivolt K, Krahl A, Lainka E, Gerner P, Lenhartz H, Vermehren J, Radke M, Trenkel S, Mayer B, Koletzko S, Debatin K, Mertens T, Posovszky C. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany. Vaccine 2020;38:1810-7. [DOI: 10.1016/j.vaccine.2019.12.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
244 Shi Y, Zhou J, Jiang B, Miao M. Resveratrol and inflammatory bowel disease. Ann N Y Acad Sci 2017;1403:38-47. [PMID: 28945937 DOI: 10.1111/nyas.13426] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
245 Kontny E, Dmowska-Chalaba J, Kwiatkowska B, Maśliński W. Cytokines and integrins related to inflammation of joint and gut in patients with spondyloarthritis and inflammatory bowel disease. Reumatologia 2017;55:276-83. [PMID: 29491535 DOI: 10.5114/reum.2017.72624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
246 Ma X, Shin YJ, Jang HM, Joo MK, Yoo JW, Kim DH. Lactobacillus rhamnosus and Bifidobacterium longum alleviate colitis and cognitive impairment in mice by regulating IFN-γ to IL-10 and TNF-α to IL-10 expression ratios. Sci Rep 2021;11:20659. [PMID: 34667205 DOI: 10.1038/s41598-021-00096-x] [Reference Citation Analysis]
247 Török S, Almási N, Valkusz Z, Pósa A, Varga C, Kupai K. Investigation of H2S Donor Treatment on Neutrophil Extracellular Traps in Experimental Colitis. Int J Mol Sci 2021;22:12729. [PMID: 34884536 DOI: 10.3390/ijms222312729] [Reference Citation Analysis]
248 Detel D, Buljevic S, Pucar LB, Kucic N, Pugel EP, Varljen J. Influence of CD26/dipeptidyl peptidase IV deficiency on immunophenotypic changes during colitis development and resolution. J Physiol Biochem 2016;72:405-19. [DOI: 10.1007/s13105-016-0491-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
249 Lee J, Moraes-Vieira PM, Castoldi A, Aryal P, Yee EU, Vickers C, Parnas O, Donaldson CJ, Saghatelian A, Kahn BB. Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Protect against Colitis by Regulating Gut Innate and Adaptive Immune Responses. J Biol Chem 2016;291:22207-17. [PMID: 27573241 DOI: 10.1074/jbc.M115.703835] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
250 Delgado ME, Brunner T. The many faces of tumor necrosis factor signaling in the intestinal epithelium. Genes Immun 2019;20:609-26. [DOI: 10.1038/s41435-019-0057-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
251 Zhu L, Shen H, Gu PQ, Liu YJ, Zhang L, Cheng JF. Baicalin alleviates TNBS-induced colitis by inhibiting PI3K/AKT pathway activation. Exp Ther Med 2020;20:581-90. [PMID: 32537016 DOI: 10.3892/etm.2020.8718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
252 Tabatabaeizadeh SA, Tafazoli N, Ferns GA, Avan A, Ghayour-Mobarhan M. Vitamin D, the gut microbiome and inflammatory bowel disease. J Res Med Sci. 2018;23:75. [PMID: 30181757 DOI: 10.4103/jrms.jrms_606_17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
253 Italiani P, Boraschi D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Front Immunol. 2014;5:514. [PMID: 25368618 DOI: 10.3389/fimmu.2014.00514] [Cited by in Crossref: 776] [Cited by in F6Publishing: 767] [Article Influence: 97.0] [Reference Citation Analysis]
254 Miró L, Amat C, Rosell-Cardona C, Campbell JM, Polo J, Pérez-Bosque A, Moretó M. Dietary Supplementation with Spray-Dried Porcine Plasma Attenuates Colon Inflammation in a Genetic Mouse Model of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E6760. [PMID: 32942624 DOI: 10.3390/ijms21186760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
255 Han X, Ding S, Jiang H, Liu G. Roles of Macrophages in the Development and Treatment of Gut Inflammation. Front Cell Dev Biol 2021;9:625423. [PMID: 33738283 DOI: 10.3389/fcell.2021.625423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
256 Cordes F, Foell D, Ding JN, Varga G, Bettenworth D. Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease. World J Gastroenterol 2020; 26(28): 4055-4075 [PMID: 32821070 DOI: 10.3748/wjg.v26.i28.4055] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
257 Danese S, Klopocka M, Scherl EJ, Romatowski J, Allegretti JR, Peeva E, Vincent MS, Schoenbeck U, Ye Z, Hassan-Zahraee M, Rath N, Li G, Neelakantan S, Banfield C, Lepsy C, Chandra DE, Hung KE. Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00614-5. [PMID: 34126262 DOI: 10.1016/j.cgh.2021.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Saad F. The emancipation of testosterone from niche hormone to multi-system player. Asian J Androl 2015;17:58-60. [PMID: 25248654 DOI: 10.4103/1008-682X.137684] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Chang Y, Lo H, Cheng S, Chang K, Lin X, Lee S, Ma J, Kuo M, Hsieh M, Chan C. Therapeutic Efficacy of Subcutaneous and Intraperitoneal Injections of a Single Dose of Human Umbilical Mesenchymal Stem Cells in Acute and Chronic Colitis in a Mouse Model. J Med Biol Eng 2020;40:82-90. [DOI: 10.1007/s40846-019-00494-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Farzaei MH, Ghasemi-Niri SF, Abdolghafari AH, Baeeri M, Khanavi M, Navaei-Nigjeh M, Abdollahi M, Rahimi R. Biochemical and histopathological evidence on the beneficial effects of Tragopogon graminifolius in TNBS-induced colitis. Pharm Biol. 2015;53:429-436. [PMID: 25471611 DOI: 10.3109/13880209.2014.923004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
261 刘海平, 姜曼, 陈朝旭, 李彦, 侯中英, 李温静, 战淑慧. 壳寡糖改善TNBS/乙醇法诱导的小鼠溃疡性结肠炎. 世界华人消化杂志 2017; 25(15): 1352-1359 [DOI: 10.11569/wcjd.v25.i15.1352] [Reference Citation Analysis]
262 da Silva BC, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol 2014;20:9458-67. [PMID: 25071340 DOI: 10.3748/wjg.v20.i28.9458] [Cited by in CrossRef: 133] [Cited by in F6Publishing: 113] [Article Influence: 16.6] [Reference Citation Analysis]
263 Lucena AMM, Souza CRM, Jales JT, Guedes PMM, de Miranda GEC, de Moura AMA, Araújo-Júnior JX, Nascimento GJ, Scortecci KC, Santos BVO, Souto JT. The Bisindole Alkaloid Caulerpin, from Seaweeds of the Genus Caulerpa, Attenuated Colon Damage in Murine Colitis Model. Mar Drugs 2018;16:E318. [PMID: 30205459 DOI: 10.3390/md16090318] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
264 Dulic S, Toldi G, Sava F, Kovács L, Molnár T, Milassin Á, Farkas K, Rutka M, Balog A. Specific T-Cell Subsets Can Predict the Efficacy of Anti-TNF Treatment in Inflammatory Bowel Diseases. Arch Immunol Ther Exp (Warsz) 2020;68:12. [PMID: 32248339 DOI: 10.1007/s00005-020-00575-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Mazieiro R, Frizon RR, Barbalho SM, Goulart RA. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases? J Med Food 2018;21:1077-85. [PMID: 29957091 DOI: 10.1089/jmf.2017.0146] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
266 El-Ashmawy NE, Khedr NF, El-Bahrawy HA, El-Adawy SA. Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis. Inflammopharmacology 2018;26:551-9. [PMID: 28707183 DOI: 10.1007/s10787-017-0373-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
267 Hvas CL, Bendix M, Dige A, Dahlerup JF, Agnholt J. Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacol Immunotoxicol 2018;40:446-60. [PMID: 29745777 DOI: 10.1080/08923973.2018.1469144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
268 Xu YW, Xing RX, Zhang WH, Li L, Wu Y, Hu J, Wang C, Luo QL, Shen JL, Chen X. Toxoplasma ROP16I/III ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages. World J Gastroenterol 2019; 25(45): 6634-6652 [PMID: 31832003 DOI: 10.3748/wjg.v25.i45.6634] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
269 Kim WK, Han DH, Jang YJ, Park S, Jang SJ, Lee G, Han HS, Ko G. Alleviation of DSS-induced colitis via Lactobacillus acidophilus treatment in mice. Food Funct 2021;12:340-50. [PMID: 33325946 DOI: 10.1039/d0fo01724h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
270 Kim DH, Cheon JH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw 2017;17:25-40. [PMID: 28261018 DOI: 10.4110/in.2017.17.1.25] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 25.8] [Reference Citation Analysis]
271 Lee Y, Jo J, Chung HY, Pothoulakis C, Im E. Endocannabinoids in the gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2016;311:G655-66. [PMID: 27538961 DOI: 10.1152/ajpgi.00294.2015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
272 Ilan Y. Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clin Transl Immunology 2016;5:e60. [PMID: 26900473 DOI: 10.1038/cti.2015.47] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
273 de Morais Lima GR, Machado FDF, Périco LL, de Faria FM, Luiz-Ferreira A, Souza Brito ARM, Pellizzon CH, Hiruma-Lima CA, Tavares JF, Barbosa Filho JM, Batista LM. Anti-inflammatory intestinal activity of Combretum duarteanum Cambess. in trinitrobenzene sulfonic acid colitis model. World J Gastroenterol 2017; 23(8): 1353-1366 [PMID: 28293082 DOI: 10.3748/wjg.v23.i8.1353] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
274 Albshesh A, Eder P, Ribaldone DG, Oldenburg B, de Boer NK, Mantzaris GJ, Savarino EV, Dragoni G, Weisshof R, Truyens M, Festa S, Maillard MH, Capirchio L, Filip R, Theodoraki E, Kopylov U. Primary hypogammaglobulinemia with IBD-like features: An ECCO CONFER Multicenter Case Series. J Crohns Colitis 2021:jjab124. [PMID: 34274962 DOI: 10.1093/ecco-jcc/jjab124] [Reference Citation Analysis]
275 Wędrychowicz A, Tomasik P, Zając A, Fyderek K. Prognostic value of assessment of stool and serum IL-1β, IL-1ra and IL-6 concentrations in children with active and inactive ulcerative colitis. Arch Med Sci 2018;14:107-14. [PMID: 29379540 DOI: 10.5114/aoms.2017.68696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
276 Kumar S, Kumar A. Microbial pathogenesis in inflammatory bowel diseases. Microb Pathog 2021;163:105383. [PMID: 34974120 DOI: 10.1016/j.micpath.2021.105383] [Reference Citation Analysis]
277 Gomes RG, Brito CAAD, Martinelli VF, Santos RND, Gomes FODS, Peixoto CA, Crispim JO, Diniz GTN, Donadi EA, Lucena-silva N. HLA-G is expressed in intestinal samples of ulcerative colitis and Crohn’s disease patients and HLA-G5 expression is differentially correlated with TNF and IL-10 cytokine expression. Human Immunology 2018;79:477-84. [DOI: 10.1016/j.humimm.2018.03.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
278 Wen N, Zhao N, Xu H, Zhao Y, Ma J. Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment. Ir J Med Sci 2021. [PMID: 34843071 DOI: 10.1007/s11845-021-02837-3] [Reference Citation Analysis]
279 Kostrzewska M, Świdnicka-Siergiejko A, Olszańska D, Jurkowska G, Garley M, Ratajczak-Wrona W, Jabłońska E, Jamiołkowski J, Dabrowski A. The effect of omeprazole treatment on the gut microflora and neutrophil function. Clin Res Hepatol Gastroenterol 2017;41:575-84. [PMID: 28258834 DOI: 10.1016/j.clinre.2017.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]